CIBC Private Wealth Group
VBIV

CIBC Private Wealth Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

CIBC Private Wealth Group’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,500
Closed -$2.63K – 3337
2024
Q2 		$2.63K Hold
3,500
– – ﹤0.01% 2695
2024
Q1 		$2.16K Buy
+3,500
New +$2.15K ﹤0.01% 2743

CIBC Private Wealth Group's VBIV Position: Q3 2024 in Review

CIBC Private Wealth Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 3,500 shares — an estimated $2.63K sold.

CIBC Private Wealth Group first reported a position in VBIV in Q1 2024 and held it in 2 quarters. The position peaked at $2.63K in Q2 2024. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

  • CIBC Private Wealth Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 3,500 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $2.63K.
  • CIBC Private Wealth Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2024 and held it in 2 quarters.
  • CIBC Private Wealth Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2.63K in Q2 2024.
  • 1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on CIBC Private Wealth Group's 13F filing for Q3 2024, filed 13 Nov 2024.